The development of novel cancer targeting agents
- Authors: Knoetze, Steyn
- Date: 2011
- Subjects: Cancer -- Research , Cancer -- Treatment
- Language: English
- Type: Thesis , Doctoral , DPhil
- Identifier: vital:10397 , http://hdl.handle.net/10948/d1010636 , Cancer -- Research , Cancer -- Treatment
- Description: The search for the cure for cancer is currently a multi-billion dollar industry and the search for the elusive “magic bullet”, i.e. the perfect cancer drug that would interact therapeutically with cancerous tissues while having a minimal effect on healthy cells, is the topic of many research studies in the world today. A large number of novel drugs or drug complexes and conjugates are being synthesized and subjected to rigorous evaluation in the race to find the perfect cure. ECDG (Ethylene diCysteine DeoxyGlucose) seems to have promising cancer targeting ability. Even though this compound has been described in a few publications, we could not find any reference to the current use of ECDG in oncology clinics, either as a therapeutic agent, or as a diagnostic tool for imaging purposes. It was also not possible to purchase pure ECDG anywhere in the world. This prompted us to further investigate ECDG as a possible candidate for cancer targeting research, either as an imaging agent for cancer diagnosis or complexed with an anti-cancer agent for therapeutic purposes. Detailed investigations done in our laboratory can be divided into the following categories: - Development of a synthetic method for ECDG on a multigram scale ; - Purification of prepared ECDG not using the described dialysis method that only allows the purification of small quantities of ECDG (mg scale) ; Detailed investigation of the chemistry involved in the preparation of pure ECDG and its metal complexes ; - Investigation of the stability of ECDG and its metal complexes that is essential data required for any pharmaceutical agent ; - Preparation of ECDG complexes for use as a diagnostic tool, i.e. complexation with 99mTc ; Investigation of the bio distribution of ECDG-ReO complexes ; - Preparation of an ECDG kit as a diagnostic tool for use in oncology clinics. The development of novel aromatic ligands having similar characteristics compared to ECDG, containing an N2S2 chromophore as donor atoms, to further investigate their targeting capabilities, have also been investigated. All intermediates and final compounds were characterized mainly by ESI MS, in some cases IR and NMR whenever available. Successful preparation and purification of ECDG ands its metal complexes was achieved and extensively characterized and evaluated. Efforts directed towards the development of ECDG at NECSA, South Africa, were also rewarded with significant success. Furthermore, significant development regarding the synthesis of two novel compounds with ECDG-like characteristics was also completed.
- Full Text:
- Date Issued: 2011
- Authors: Knoetze, Steyn
- Date: 2011
- Subjects: Cancer -- Research , Cancer -- Treatment
- Language: English
- Type: Thesis , Doctoral , DPhil
- Identifier: vital:10397 , http://hdl.handle.net/10948/d1010636 , Cancer -- Research , Cancer -- Treatment
- Description: The search for the cure for cancer is currently a multi-billion dollar industry and the search for the elusive “magic bullet”, i.e. the perfect cancer drug that would interact therapeutically with cancerous tissues while having a minimal effect on healthy cells, is the topic of many research studies in the world today. A large number of novel drugs or drug complexes and conjugates are being synthesized and subjected to rigorous evaluation in the race to find the perfect cure. ECDG (Ethylene diCysteine DeoxyGlucose) seems to have promising cancer targeting ability. Even though this compound has been described in a few publications, we could not find any reference to the current use of ECDG in oncology clinics, either as a therapeutic agent, or as a diagnostic tool for imaging purposes. It was also not possible to purchase pure ECDG anywhere in the world. This prompted us to further investigate ECDG as a possible candidate for cancer targeting research, either as an imaging agent for cancer diagnosis or complexed with an anti-cancer agent for therapeutic purposes. Detailed investigations done in our laboratory can be divided into the following categories: - Development of a synthetic method for ECDG on a multigram scale ; - Purification of prepared ECDG not using the described dialysis method that only allows the purification of small quantities of ECDG (mg scale) ; Detailed investigation of the chemistry involved in the preparation of pure ECDG and its metal complexes ; - Investigation of the stability of ECDG and its metal complexes that is essential data required for any pharmaceutical agent ; - Preparation of ECDG complexes for use as a diagnostic tool, i.e. complexation with 99mTc ; Investigation of the bio distribution of ECDG-ReO complexes ; - Preparation of an ECDG kit as a diagnostic tool for use in oncology clinics. The development of novel aromatic ligands having similar characteristics compared to ECDG, containing an N2S2 chromophore as donor atoms, to further investigate their targeting capabilities, have also been investigated. All intermediates and final compounds were characterized mainly by ESI MS, in some cases IR and NMR whenever available. Successful preparation and purification of ECDG ands its metal complexes was achieved and extensively characterized and evaluated. Efforts directed towards the development of ECDG at NECSA, South Africa, were also rewarded with significant success. Furthermore, significant development regarding the synthesis of two novel compounds with ECDG-like characteristics was also completed.
- Full Text:
- Date Issued: 2011
Purification and characterization of fructosyltransferase for the synthesis of short-chain fructo-oligosaccharides and investigation into thier anti-carcinogenic properties
- Authors: Nemukula, Aluwani
- Date: 2009
- Subjects: Oligosaccharides , Polygalacturonase , Aspergillus , Fructose , Inulin , Cancer -- Prevention , Cancer -- Research , Carcinogens , High performance liquid chromatography
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:3927 , http://hdl.handle.net/10962/d1003986 , Oligosaccharides , Polygalacturonase , Aspergillus , Fructose , Inulin , Cancer -- Prevention , Cancer -- Research , Carcinogens , High performance liquid chromatography
- Description: There is a growing attention in the synthesis of fructo-oligosaccharides (FOS) due to their excellent bio-functional and health-promoting properties. The current production processes are limited to chemical hydrolysis reactions of plant extracts, which are often associated with several drawbacks. In this study, fructosyltransferase (FTase) and polygalacturonase (PGase) activities, present in a commercial enzyme preparation (Pectinex® Ultra SP-L) sourced from Aspergillus aculeatus, have been separated and fully purified by anion-exchange and sizeexclusion chromatography. The FTase possesses fructosyl transfer activity for FOS synthesis and the PGase has pectin hydrolytic activity. Fructosyltransferase is a single-band protein with a molecular weight of 85 kDa, whereas PGase is a distinct protein of 40 kDa. The temperature and pH optima of FTase were 60 ºC and 6.0, with a half-life of 8 h; while that for PGase were 40 ºC and 6.0, respectively. FTase was slightly inhibited in the presence of Ni²⁺, Mg²⁺ and urea; but PGase was more susceptible to divalent ions such as Ca²⁺, Mg²⁺ and Mn²⁺. The kinetic parameters (Km and Vmax) of FTase for the hydrolysis of β-(2→1) linkages from sucrose were 752.3 mM and 120.5 μmol.min⁻¹.mL⁻¹, respectively; whereas the same parameters for pectin hydrolysis by PGase were 13.0 mg.mL⁻¹ and 263 μmol.min-1.mL⁻¹, respectively. The purified FTase was able to transfer fructosyl residues from sucrose, synthesizing the corresponding chains of FOS. PGase was relatively stable at 40 ºC (t½ > 3 h), depolymerizing the pectin backbone while releasing the inulins from within the chicory roots. Analysis of various mixtures of FOS by mass spectrometry, HPLC and ¹H-NMR was undertaken. Results indicated that MS with electrospray ionization and ¹H-NMR are capable of providing relative quantitative data of the FOS present in the mixtures. The pharmaceutical effects of various sc-FOS (0.5%, v/v) and SCFA (0.3%, v/v) on certain bacterial enzymes (β-glucuronidase, urease and β-glucosidase) associated with the formation of carcinogens were also studied. These enzyme activities were not directly influenced by the sc-FOS, but were found to be remarkably decreased by SCFA, pointing toward the prebiotic effect of FOS in intestinal microflora modulation.
- Full Text:
- Date Issued: 2009
- Authors: Nemukula, Aluwani
- Date: 2009
- Subjects: Oligosaccharides , Polygalacturonase , Aspergillus , Fructose , Inulin , Cancer -- Prevention , Cancer -- Research , Carcinogens , High performance liquid chromatography
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:3927 , http://hdl.handle.net/10962/d1003986 , Oligosaccharides , Polygalacturonase , Aspergillus , Fructose , Inulin , Cancer -- Prevention , Cancer -- Research , Carcinogens , High performance liquid chromatography
- Description: There is a growing attention in the synthesis of fructo-oligosaccharides (FOS) due to their excellent bio-functional and health-promoting properties. The current production processes are limited to chemical hydrolysis reactions of plant extracts, which are often associated with several drawbacks. In this study, fructosyltransferase (FTase) and polygalacturonase (PGase) activities, present in a commercial enzyme preparation (Pectinex® Ultra SP-L) sourced from Aspergillus aculeatus, have been separated and fully purified by anion-exchange and sizeexclusion chromatography. The FTase possesses fructosyl transfer activity for FOS synthesis and the PGase has pectin hydrolytic activity. Fructosyltransferase is a single-band protein with a molecular weight of 85 kDa, whereas PGase is a distinct protein of 40 kDa. The temperature and pH optima of FTase were 60 ºC and 6.0, with a half-life of 8 h; while that for PGase were 40 ºC and 6.0, respectively. FTase was slightly inhibited in the presence of Ni²⁺, Mg²⁺ and urea; but PGase was more susceptible to divalent ions such as Ca²⁺, Mg²⁺ and Mn²⁺. The kinetic parameters (Km and Vmax) of FTase for the hydrolysis of β-(2→1) linkages from sucrose were 752.3 mM and 120.5 μmol.min⁻¹.mL⁻¹, respectively; whereas the same parameters for pectin hydrolysis by PGase were 13.0 mg.mL⁻¹ and 263 μmol.min-1.mL⁻¹, respectively. The purified FTase was able to transfer fructosyl residues from sucrose, synthesizing the corresponding chains of FOS. PGase was relatively stable at 40 ºC (t½ > 3 h), depolymerizing the pectin backbone while releasing the inulins from within the chicory roots. Analysis of various mixtures of FOS by mass spectrometry, HPLC and ¹H-NMR was undertaken. Results indicated that MS with electrospray ionization and ¹H-NMR are capable of providing relative quantitative data of the FOS present in the mixtures. The pharmaceutical effects of various sc-FOS (0.5%, v/v) and SCFA (0.3%, v/v) on certain bacterial enzymes (β-glucuronidase, urease and β-glucosidase) associated with the formation of carcinogens were also studied. These enzyme activities were not directly influenced by the sc-FOS, but were found to be remarkably decreased by SCFA, pointing toward the prebiotic effect of FOS in intestinal microflora modulation.
- Full Text:
- Date Issued: 2009
Metabolic responses to in vitro zinc supplementation
- Authors: Steel, Helen Carolyn
- Date: 1994
- Subjects: Zinc in the body , Zinc -- Physiological effect , Cancer -- Research
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:4040 , http://hdl.handle.net/10962/d1004101 , Zinc in the body , Zinc -- Physiological effect , Cancer -- Research
- Description: The present study was carried out to determine the effects and possible mechanism of action of zinc supplementation on the in vitro growth of malignant murine melanoma (B16) and non-malignant monkey kidney (LLCMK) cells. Cell culture studies showed that zinc supplementation significantly inhibited B16 growth at all the concentrations studied (1, 3, 5 and lOμg/ml). Zinc was also found to inhibit the growth of the LLCMK cells, although to a lesser extent than the B16 cells. Possible evidence of mobilisation of the essential fatty acids from the membrane phospholipid stores was noted in both cell types. This effect was, however, greater in the B16 cells. Δ⁶-desaturase activity was found to be significantly lower in the B16 cells than in the LLCMK cells (p ≥ 0.05). Zinc supplementation resulted in an increase in the enzymes activity in the LLCMK cells and, at high concentrations, in the B16 cells. An estimation of elongase and Δ⁶-desaturase activity with zinc supplementation indicated that zinc had little or no effect on the activity of these enzymes. B16 cells were found to have higher levels of free radicals than the LLCMK cells. Zinc supplementation resulted in increased free radical formation in the B16 cells, while no effect was observed in the LLCMK cells. Lipid peroxidation increased in both cell types with increased zinc concentrations. The observed effect of zinc supplementation on cell growth may involve these elevated levels of lipid peroxides. CycIo-oxygenase activity was found to be greater in the B16 cells than the LLCMK cells. The activity of the enzyme increased with higher concentrations of zinc (lOμg/ml) in both cell types. Prostaglandin E, levels were found to be lower in the B16 cells compared to the LLCMK cells. The levels of prostaglandin E, in both cell types appeared to be dependent on the levels of the polyunsaturated fatty acid precursors to the prostaglandins. Zinc was found to inhibit the activity of the enzyme adenylate cyclase in both cell types. The cAMP levels in the LLCMK cells were also found to decrease with zinc supplementation. In the case of the B16 cells, cAMP levels increased at low concentrations of zinc despite a decrease in adenyl ate cyclase activity, suggesting a possible inhibition of cAMP phosphodiesterase activity at these concentrations of zinc. It is concluded that although zinc supplementation does have an effect on cell growth, this effect is not mediated through the activation of adenylate cyclase by the prostaglandins resulting in elevated levels of cAMP. A possible mechanism involving lipid peroxidation is proposed.
- Full Text:
- Date Issued: 1994
- Authors: Steel, Helen Carolyn
- Date: 1994
- Subjects: Zinc in the body , Zinc -- Physiological effect , Cancer -- Research
- Language: English
- Type: Thesis , Masters , MSc
- Identifier: vital:4040 , http://hdl.handle.net/10962/d1004101 , Zinc in the body , Zinc -- Physiological effect , Cancer -- Research
- Description: The present study was carried out to determine the effects and possible mechanism of action of zinc supplementation on the in vitro growth of malignant murine melanoma (B16) and non-malignant monkey kidney (LLCMK) cells. Cell culture studies showed that zinc supplementation significantly inhibited B16 growth at all the concentrations studied (1, 3, 5 and lOμg/ml). Zinc was also found to inhibit the growth of the LLCMK cells, although to a lesser extent than the B16 cells. Possible evidence of mobilisation of the essential fatty acids from the membrane phospholipid stores was noted in both cell types. This effect was, however, greater in the B16 cells. Δ⁶-desaturase activity was found to be significantly lower in the B16 cells than in the LLCMK cells (p ≥ 0.05). Zinc supplementation resulted in an increase in the enzymes activity in the LLCMK cells and, at high concentrations, in the B16 cells. An estimation of elongase and Δ⁶-desaturase activity with zinc supplementation indicated that zinc had little or no effect on the activity of these enzymes. B16 cells were found to have higher levels of free radicals than the LLCMK cells. Zinc supplementation resulted in increased free radical formation in the B16 cells, while no effect was observed in the LLCMK cells. Lipid peroxidation increased in both cell types with increased zinc concentrations. The observed effect of zinc supplementation on cell growth may involve these elevated levels of lipid peroxides. CycIo-oxygenase activity was found to be greater in the B16 cells than the LLCMK cells. The activity of the enzyme increased with higher concentrations of zinc (lOμg/ml) in both cell types. Prostaglandin E, levels were found to be lower in the B16 cells compared to the LLCMK cells. The levels of prostaglandin E, in both cell types appeared to be dependent on the levels of the polyunsaturated fatty acid precursors to the prostaglandins. Zinc was found to inhibit the activity of the enzyme adenylate cyclase in both cell types. The cAMP levels in the LLCMK cells were also found to decrease with zinc supplementation. In the case of the B16 cells, cAMP levels increased at low concentrations of zinc despite a decrease in adenyl ate cyclase activity, suggesting a possible inhibition of cAMP phosphodiesterase activity at these concentrations of zinc. It is concluded that although zinc supplementation does have an effect on cell growth, this effect is not mediated through the activation of adenylate cyclase by the prostaglandins resulting in elevated levels of cAMP. A possible mechanism involving lipid peroxidation is proposed.
- Full Text:
- Date Issued: 1994
- «
- ‹
- 1
- ›
- »